Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Pennsylvania

University of Pennsylvania in Philadelphia, Pennsylvania, United States is listed as a site for 2,090 registered clinical trials, 579 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,090
Ongoing 579

This page covers the site record University of Pennsylvania in Philadelphia, Pennsylvania, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Pennsylvania, also sponsors trials.

Get the University of Pennsylvania report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,090 trials counted.

  • Phase 1 190 trials
  • Phase 1/2 96 trials
  • Phase 2 365 trials
  • Phase 2/3 40 trials
  • Phase 3 295 trials
  • Phase 4 99 trials
  • Not applicable 646 trials
  • Observational 351 trials
  • Expanded access 8 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 581 trials
  • Completed 1,233 trials
  • Terminated 232 trials
  • Other 44 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 139

1990: 1 trials (Phase 2 1) 1991: 3 trials (Phase 2 2, Phase 1 1) 1992: 2 trials (Phase 2 2) 1993: 1 trials (Observational 1) 1994: 2 trials (Phase 3 1, Phase 1 1) 1995: 1 trials (Phase 3 1) 1996: 5 trials (Phase 2 3, Phase 1 2) 1998: 2 trials (Phase 3 2) 1999: 8 trials (Observational 1, Not applicable 1, Phase 4 2, Phase 3 2, Phase 2 2) 2000: 6 trials (Not applicable 2, Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2001: 7 trials (Observational 2, Not applicable 2, Phase 3 1, Phase 2/3 1, Phase 1/2 1) 2002: 10 trials (Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 2 2) 2003: 32 trials (Observational 7, Not applicable 3, Phase 4 3, Phase 3 7, Phase 2/3 5, Phase 2 4, Phase 1/2 1, Phase 1 2) 2004: 24 trials (Observational 3, Not applicable 2, Phase 4 4, Phase 3 8, Phase 2/3 1, Phase 2 5, Phase 1 1) 2005: 37 trials (Observational 3, Not applicable 8, Phase 4 3, Phase 3 10, Phase 2 8, Phase 1/2 2, Phase 1 3) 2006: 50 trials (Observational 11, Not applicable 5, Phase 4 4, Phase 3 6, Phase 2/3 1, Phase 2 17, Phase 1/2 1, Phase 1 5) 2007: 34 trials (Observational 8, Not applicable 4, Phase 4 3, Phase 3 6, Phase 2 9, Phase 1 4) 2008: 48 trials (Observational 7, Not applicable 6, Phase 4 5, Phase 3 6, Phase 2/3 1, Phase 2 13, Phase 1/2 3, Phase 1 7) 2009: 61 trials (Observational 7, Not applicable 15, Phase 4 5, Phase 3 7, Phase 2 18, Phase 1/2 3, Phase 1 6) 2010: 74 trials (Observational 18, Not applicable 16, Phase 4 3, Phase 3 16, Phase 2/3 2, Phase 2 13, Phase 1/2 3, Phase 1 3) 2011: 72 trials (Observational 13, Not applicable 23, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 21, Phase 1/2 3, Phase 1 3) 2012: 58 trials (Observational 7, Not applicable 20, Phase 4 2, Phase 3 13, Phase 2 11, Phase 1/2 3, Phase 1 2) 2013: 78 trials (Observational 14, Not applicable 27, Phase 4 5, Phase 3 11, Phase 2/3 2, Phase 2 13, Phase 1/2 2, Phase 1 4) 2014: 91 trials (Observational 11, Not applicable 34, Phase 4 5, Phase 3 14, Phase 2 15, Phase 1/2 5, Phase 1 7) 2015: 83 trials (Observational 18, Not applicable 27, Phase 4 5, Phase 3 11, Phase 2 12, Phase 1/2 8, Phase 1 2) 2016: 117 trials (Observational 26, Not applicable 35, Phase 4 6, Phase 3 18, Phase 2/3 3, Phase 2 16, Phase 1/2 7, Phase 1 6) 2017: 124 trials (Observational 19, Not applicable 36, Phase 4 8, Phase 3 14, Phase 2/3 1, Phase 2 27, Phase 1/2 5, Phase 1 14) 2018: 114 trials (Observational 14, Not applicable 42, Phase 4 4, Phase 3 18, Phase 2 21, Phase 1/2 5, Phase 1 10) 2019: 138 trials (Observational 25, Not applicable 39, Phase 4 6, Phase 3 27, Phase 2 20, Phase 1/2 6, Phase 1 15) 2020: 115 trials (Observational 24, Not applicable 32, Phase 4 8, Phase 3 17, Phase 2/3 2, Phase 2 13, Phase 1/2 6, Phase 1 13) 2021: 126 trials (Observational 22, Not applicable 53, Phase 4 2, Phase 3 6, Phase 2/3 2, Phase 2 21, Phase 1/2 7, Phase 1 13) 2022: 127 trials (Observational 18, Not applicable 56, Phase 4 4, Phase 3 13, Phase 2/3 4, Phase 2 15, Phase 1/2 4, Phase 1 13) 2023: 139 trials (Observational 23, Not applicable 51, Phase 4 4, Phase 3 14, Phase 2/3 2, Phase 2 19, Phase 1/2 6, Phase 1 20) 2024: 105 trials (Observational 27, Not applicable 33, Phase 4 4, Phase 3 9, Phase 2/3 2, Phase 2 13, Phase 1/2 6, Phase 1 11) 2025: 101 trials (Observational 15, Not applicable 34, Phase 4 1, Phase 3 11, Phase 2/3 6, Phase 2 18, Phase 1/2 6, Phase 1 10)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 72
2025 101
2024 105
2023 139
2022 127
2021 126
2020 115
2019 138
2018 114
2017 124

Showing 10 of 36 years.

Start your 14-day trial Email me all 36 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 2,090 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 425 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 721 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF